Value-Based Benefits: The Impact of Pharmacy Plan Design
Without key, cross-silo information, employers that implement medical cost controls for employees run the risk of discouraging treatment essential to employees' health-related productivity and quality of life. This IBI study, relying on a master database furnished by Ingenix, demonstrates the unanticipated consequences in increased short-term disability and lost productivity for rheumatoid arthritis (RA) that can occur when employers increase out-of-pocket expenses for necessary medications. If new "value-based benefit designs" are truly going to add demonstrated value, they must draw treatment, cost and impact links across traditional benefits lines through an integrated database.
IBI has created a short presentation below on this research. IBI members are invited to use the presentation (downloadable as a PPT, below) with attribution to IBI and the other sources cited. The accompanying commentary may be seen in the notes of the presentation upon download. Summaries of the research and the full report also are available on our website.
Pharma Slide Deck
Download the presentation from SlideShare
View more presentations from Integrated Benefits Institute
